跳至主要内容
临床试验/ACTRN12618000893202
ACTRN12618000893202已完成未知

'Neonatal Encephalopathy Brain Outcomes (NEBO): Biomarkers in term born infants to improve accurate and earlier prediction of Cerebral Palsy

Prof Roslyn Boyd0 个研究点目标入组 64 人开始时间: 2018年5月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
35 Weeks 至 42 Weeks(—)
性别
All

入选标准

  • (a) All babies who enter the Paean Trial, are eligible for the NEBO follow-up trial.
  • (b) Moderate to severe encephalopathy in the first 7 days after term delivery (greater than 35 plus weeks PMA) using the modified Sarnat classification;
  • (c) Male or female infants born at 35 plus 0 weeks gestation with HIE (perinatal depression).
  • (d) One or more of the following indications of perinatal depression:
  • Apgar of 5 at 10 minutes after birth OR
  • receiving ongoing resuscitation e.g. assisted ventilation (positive pressure ventilation or CPAP) or chest compressions at 10 minutes after birth OR
  • on cord blood or arterial or venous blood obtained at less than 60 minutes after birth,
  • pH less than 7.00 OR
  • base deficit of 12.0 mmol/L.
  • e) Moderate to severe encephalopathy, defined between one and six hours after birth by one or both of the following:
  • 3 out of 6 modified Sarnat criteria indicating moderate/severe encephalopathy;
  • 2 out of 6 modified Sarnat criteria between one and six hours after birth, plus seizure(s) requiring anticonvulsant treatment (diagnosed either clinically or using EEG monitoring) at any time of study entry;
  • f) Hypothermia treatment initiated by 6 hours of age; i.e. controlled whole-body cooling planned to continue for 72 hours, to a target temperature (adjusted manually or with a device) and subsequent controlled re-warming
  • g) Informed consent;
  • h) Ability to receive 3T MRI at 1-10 days post-delivery (day 5-7 optimal) at 35+ weeks PMA (no metal inserts; i.e. no VP shunts)
  • In ADDITION the following babies not entered into the PAEAN intervention trial would be eligible for the NEBO observational trial:
  • i.Babies cooled too late
  • ii.Postnatal arrest with subsequent HIE
  • iii.Parents not approached (e.g. mother in ICU/too ill on 1st day)
  • iv.Babies whose parents declined PAEAN (not happy about an intervention trial but would agree to an observational study).
  • v.Babies who met all other criteria for PAEAN but had a contraindication to cooling – e.g. uncontrolled pulmonary hypertension or coagulopathy/bleeding – so didn’t get cooled.
  • Healthy term reference group:
  • a) born between 35 and 42 weeks gestation following an uncomplicated pregnancy and delivery,
  • b) have a birth weight above the 10th percentile
  • c) not admitted to neonatal intensive or special care units following their birth.

排除标准

  • (a)Unable to return for follow-up;
  • (b)Children with major congenital anomalies
  • (c)Where cessation of life support is under active discussion

研究者

发起方
Prof Roslyn Boyd

相似试验